ETF Holdings Breakdown of WGS

Stock Name	GeneDx Holdings Corp.
Ticker	WGS(USD) NASDAQ
TYPE	Common Stock
Country	USA

WGS institutional holdings

The following institutional investment holdings of WGS have been identified

Date ETF ISIN/Name Num Shares Book value
2025-09-26 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 13,277 USD 1,556,197

2025-09-26 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 6,571 USD 770,187

2025-09-26 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 147 USD 17,230 3.6%

Total = 19,995 USD 2,343,614
Book value of shares is calculated on the adjusted close price of each day (row).

Date	ETF ISIN/Name	Num Shares	Book value
2025-09-26	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	13,277	USD 1,556,197
2025-09-26	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	6,571	USD 770,187
2025-09-26	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	147	USD 17,230 3.6%
Total =	19,995	USD 2,343,614

News associated with WGS

GeneDx (NASDAQ:WGS) & Ramsay Health Care (OTCMKTS:RMYHY) Head to Head Review: GeneDx (NASDAQ:WGS – Get Free Report) and Ramsay Health Care (OTCMKTS:RMYHY – Get Free Report) are both mid-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and earnings. Analyst Ratings This is a summary of […] - 2025-09-02 05:07:04
GeneDx (NASDAQ:WGS) Shares Down 5.1% After Insider Selling: GeneDx Holdings Corp. (NASDAQ:WGS – Get Free Report)’s stock price dropped 5.1% during trading on Monday after an insider sold shares in the company. The company traded as low as $122.42 and last traded at $122.10. Approximately 325,200 shares changed hands during mid-day trading, a decline of 69% from the average daily volume of 1,062,925 […] - 2025-08-27 02:16:59
Brokerages Set GeneDx Holdings Corp. (NASDAQ:WGS) PT at $101.63: GeneDx Holdings Corp. (NASDAQ:WGS – Get Free Report) has received a consensus rating of “Moderate Buy” from the eight analysts that are presently covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 1-year price target among […] - 2025-08-15 02:24:50
GeneDx (NASDAQ:WGS) Stock Price Expected to Rise, Piper Sandler Analyst Says: GeneDx (NASDAQ:WGS – Free Report) had its target price raised by Piper Sandler from $110.00 to $120.00 in a research report report published on Monday,Benzinga reports. Piper Sandler currently has an overweight rating on the stock. A number of other research analysts also recently commented on WGS. Wells Fargo & Company increased their price objective […] - 2025-08-05 04:32:50
GeneDx (NASDAQ:WGS) Stock Rating Upgraded by Wall Street Zen: Wall Street Zen upgraded shares of GeneDx (NASDAQ:WGS – Free Report) from a hold rating to a buy rating in a research note released on Saturday morning. Several other research analysts have also recently issued reports on the company. TD Securities cut their price objective on GeneDx from $135.00 to $110.00 and set a “buy” […] - 2025-08-05 02:56:49
GeneDx (NASDAQ:WGS) Price Target Raised to $95.00: GeneDx (NASDAQ:WGS – Get Free Report) had its target price raised by equities researchers at Wells Fargo & Company from $78.00 to $95.00 in a research report issued on Wednesday,Benzinga reports. The firm currently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price objective points to a potential downside of 6.82% […] - 2025-08-01 04:42:53
GeneDx (NASDAQ:WGS) Shares Gap Up After Earnings Beat: GeneDx Holdings Corp. (NASDAQ:WGS – Get Free Report) shares gapped up prior to trading on Tuesday following a better than expected earnings announcement. The stock had previously closed at $84.91, but opened at $105.31. GeneDx shares last traded at $94.37, with a volume of 926,890 shares trading hands. The company reported $0.50 earnings per share […] - 2025-07-31 02:22:52
Arizona State Retirement System Has $415,000 Stake in GeneDx Holdings Corp. (NASDAQ:WGS): Arizona State Retirement System lifted its stake in shares of GeneDx Holdings Corp. (NASDAQ:WGS – Free Report) by 33.8% during the first quarter, Holdings Channel.com reports. The firm owned 4,686 shares of the company’s stock after acquiring an additional 1,185 shares during the period. Arizona State Retirement System’s holdings in GeneDx were worth $415,000 as […] - 2025-07-23 05:08:54
GeneDx Holdings Corp. (NASDAQ:WGS) Receives $92.33 Consensus Price Target from Analysts: Shares of GeneDx Holdings Corp. (NASDAQ:WGS – Get Free Report) have earned an average recommendation of “Moderate Buy” from the nine research firms that are currently covering the company, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 1 […] - 2025-07-21 02:30:49
GeneDx (NASDAQ:WGS) Downgraded to Hold Rating by Wall Street Zen: GeneDx (NASDAQ:WGS – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “buy” rating to a “hold” rating in a report released on Sunday. Several other brokerages have also recently weighed in on WGS. TD Securities dropped their price target on shares of GeneDx from $135.00 to $110.00 and set […] - 2025-07-15 03:06:58
Allspring Global Investments Holdings LLC Has $16.10 Million Stake in GeneDx Holdings Corp. (NASDAQ:WGS): Allspring Global Investments Holdings LLC raised its holdings in GeneDx Holdings Corp. (NASDAQ:WGS – Free Report) by 111.1% during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 190,297 shares of the company’s stock after purchasing an additional 100,146 shares during the quarter. Allspring […] - 2025-07-03 05:31:07
GeneDx Holdings Corp. (NASDAQ:WGS) Receives $86.75 Average Price Target from Brokerages: GeneDx Holdings Corp. (NASDAQ:WGS – Get Free Report) has been given an average recommendation of “Moderate Buy” by the eight ratings firms that are currently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 1 year […] - 2025-06-26 02:23:02
SG Americas Securities LLC Increases Stock Position in GeneDx Holdings Corp. (NASDAQ:WGS): SG Americas Securities LLC boosted its stake in GeneDx Holdings Corp. (NASDAQ:WGS – Free Report) by 19.6% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 10,451 shares of the company’s stock after acquiring an additional 1,716 shares during the period. […] - 2025-06-19 04:32:51
Oversold Conditions For GeneDx Holdings (WGS): Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me - 2025-06-13 12:58:52
15,937 Shares in GeneDx Holdings Corp. (NASDAQ:WGS) Bought by Harbor Capital Advisors Inc.: Harbor Capital Advisors Inc. acquired a new stake in shares of GeneDx Holdings Corp. (NASDAQ:WGS – Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 15,937 shares of the company’s stock, valued at approximately $1,411,000. Harbor Capital Advisors Inc. owned […] - 2025-06-13 04:56:57
California State Teachers Retirement System Boosts Stake in GeneDx Holdings Corp. (NASDAQ:WGS): California State Teachers Retirement System raised its position in GeneDx Holdings Corp. (NASDAQ:WGS – Free Report) by 13.3% during the fourth quarter, HoldingsChannel.com reports. The firm owned 11,384 shares of the company’s stock after purchasing an additional 1,335 shares during the period. California State Teachers Retirement System’s holdings in GeneDx were worth $875,000 at the […] - 2025-06-11 05:02:49
Ameriprise Financial Inc. Buys Shares of 34,407 GeneDx Holdings Corp. (NASDAQ:WGS): Ameriprise Financial Inc. bought a new stake in shares of GeneDx Holdings Corp. (NASDAQ:WGS – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 34,407 shares of the company’s stock, valued at approximately $2,645,000. Several other large investors have also recently […] - 2025-05-29 05:52:48
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $552,000 Stake in GeneDx Holdings Corp. (NASDAQ:WGS): MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in GeneDx Holdings Corp. (NASDAQ:WGS – Free Report) by 7.7% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 7,188 shares of the company’s stock after buying an additional 515 shares during the quarter. MIRAE ASSET […] - 2025-05-29 04:36:51
State of Wyoming Reduces Stock Holdings in GeneDx Holdings Corp. (NASDAQ:WGS): State of Wyoming reduced its stake in GeneDx Holdings Corp. (NASDAQ:WGS – Free Report) by 62.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,249 shares of the company’s stock after selling 2,093 shares during the period. State of Wyoming’s holdings in […] - 2025-05-28 05:14:53
Nuveen Asset Management LLC Grows Stock Position in GeneDx Holdings Corp. (NASDAQ:WGS): Nuveen Asset Management LLC lifted its stake in shares of GeneDx Holdings Corp. (NASDAQ:WGS – Free Report) by 1.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 197,365 shares of the company’s stock after purchasing an additional 3,084 shares during the […] - 2025-05-26 04:54:59
BNP Paribas Financial Markets Purchases Shares of 56,588 GeneDx Holdings Corp. (NASDAQ:WGS): BNP Paribas Financial Markets bought a new position in shares of GeneDx Holdings Corp. (NASDAQ:WGS – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 56,588 shares of the company’s stock, valued at approximately $4,349,000. BNP Paribas Financial Markets […] - 2025-05-15 05:06:49
MetLife Investment Management LLC Purchases 453 Shares of GeneDx Holdings Corp. (NASDAQ:WGS): MetLife Investment Management LLC increased its position in GeneDx Holdings Corp. (NASDAQ:WGS – Free Report) by 6.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,750 shares of the company’s stock after buying an additional 453 shares during the period. MetLife […] - 2025-05-05 05:30:48
Legal & General Group Plc Purchases 2,638 Shares of GeneDx Holdings Corp. (NASDAQ:WGS): Legal & General Group Plc increased its position in shares of GeneDx Holdings Corp. (NASDAQ:WGS – Free Report) by 31.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,123 shares of the company’s stock after acquiring an additional 2,638 […] - 2025-04-28 04:56:53
GeneDx Holdings Reaches Analyst Target Price: In recent trading, shares of GeneDx Holdings Corp (Symbol: WGS) have crossed above the average analyst 12-month target price of $107.33, changing hands for $109.39/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade o - 2025-04-25 08:00:43
GeneDx Holdings Corp. (NASDAQ:WGS) Shares Acquired by JPMorgan Chase & Co.: JPMorgan Chase & Co. boosted its holdings in GeneDx Holdings Corp. (NASDAQ:WGS – Free Report) by 106.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 107,891 shares of the company’s stock after acquiring an additional 55,730 shares during the period. JPMorgan […] - 2025-04-16 04:31:01
Wellington Management Group LLP Buys Shares of 140,792 GeneDx Holdings Corp. (NASDAQ:WGS): Wellington Management Group LLP bought a new stake in GeneDx Holdings Corp. (NASDAQ:WGS – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 140,792 shares of the company’s stock, valued at approximately $10,821,000. Wellington Management Group LLP […] - 2025-04-10 06:23:16
68,000 Shares in GeneDx Holdings Corp. (NASDAQ:WGS) Acquired by Norges Bank: Norges Bank purchased a new stake in GeneDx Holdings Corp. (NASDAQ:WGS – Free Report) during the fourth quarter, Holdings Channel reports. The firm purchased 68,000 shares of the company’s stock, valued at approximately $5,226,000. Several other hedge funds have also recently bought and sold shares of the stock. JPMorgan Chase & Co. boosted its stake […] - 2025-04-10 05:22:54
Corebridge Financial Inc. Sells 346 Shares of GeneDx Holdings Corp. (NASDAQ:WGS): Corebridge Financial Inc. reduced its holdings in GeneDx Holdings Corp. (NASDAQ:WGS – Free Report) by 5.2% during the fourth quarter, Holdings Channel.com reports. The fund owned 6,352 shares of the company’s stock after selling 346 shares during the quarter. Corebridge Financial Inc.’s holdings in GeneDx were worth $488,000 at the end of the most recent […] - 2025-04-09 04:44:46
Insider Selling: GeneDx Holdings Corp. (NASDAQ:WGS) CEO Sells $4,451,206.62 in Stock: GeneDx Holdings Corp. (NASDAQ:WGS – Get Free Report) CEO Katherine Stueland sold 46,551 shares of GeneDx stock in a transaction that occurred on Wednesday, March 26th. The shares were sold at an average price of $95.62, for a total transaction of $4,451,206.62. Following the sale, the chief executive officer now directly owns 48,314 shares in […] - 2025-03-31 05:06:50
GeneDx Holdings Corp. (NASDAQ:WGS) CFO Kevin Feeley Sells 8,746 Shares: GeneDx Holdings Corp. (NASDAQ:WGS – Get Free Report) CFO Kevin Feeley sold 8,746 shares of the firm’s stock in a transaction dated Wednesday, March 26th. The shares were sold at an average price of $95.61, for a total transaction of $836,205.06. Following the transaction, the chief financial officer now directly owns 15,996 shares in the […] - 2025-03-31 05:06:47

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.